Table 1.
Demographical and Clinical Data of Patients Infected With Yellow Fever Virus
| Survivors (n = 27) | Missing Values | Nonsurvivors (n = 27) | Missing Values | P Value | |
|---|---|---|---|---|---|
| Gender: male, % | 100 | 0 | 100 | 0 | >.99 |
| Age, y | 44 (35–57) | 0 | 50 (36–63) | 0 | .37 |
| Days of symptoms | 7 (6–9) | 0 | 7 (5–9) | 0 | .83 |
| Viral load, log10 copies/mL | 4.4 (3.8–6.3) | 5 | 5.6 (5.0–6.4) | 1 | .08 |
| Alanine transaminase, U/L | 2339 (1248–2778) | 4 | 2370 (1634–5194) | 4 | .77 |
| Aspartate transaminase, U/L | 2238 (856–3868) | 3 | 6103 (3648–14.913) | 4 | .001 |
| Prothrombin time, s | 14.1 (11.0–16.0) | 2 | 23.1 (17.1–36.8) | 4 | <.001 |
| Creatinine, mg/dL | 0.93 (0.77–1.10) | 5 | 4.09 (2.98–5.35) | 5 | <.001 |
| Count/μL | |||||
| Leukocyte | 3100 (2150–4160) | 2 | 5885 (4280–11 525) | 1 | <.001 |
| Neutrophil | 1470 (1185–1915) | 2 | 4830 (3133–9078) | 1 | <.001 |
| Lymphocyte | 700 (530–1365) | 2 | 815 (535–1628) | 1 | .019 |
| Platelet | 90 (57–109) | 7 | 80 (46–101) | 5 | .50 |
Data are presented as median (IQR) unless noted otherwise.